Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Pharmacy|March 1, 1985
Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failureD S Roffman, M M Applefeld, W R Grove, et al.
American Heart Journal|September 1, 1987
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patientsM M Applefeld, K A Newman, F J Sutton, et al.
The American Journal of Cardiology|February 1, 1983
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failureM M Applefeld, K A Newman, W R Grove, et al.
Investigational New Drugs|January 1, 1997
A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumorsN T Sklarin, C D Lathia, L Benson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase II trial of diaziquone in patients with head and neck cancerF Muñiz, E Vélez-García, J A Neidhart, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsR S Finley, C L Fortner, C A deJongh, et al.
Cancer Treatment Reports|March 1, 1986
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomasH S Greenberg, W D Ensminger, P B Layton, et al.
Investigational New Drugs|November 1, 1992
A phase II trial of CI-921 in advanced malignanciesN T Sklarin, P H Wiernik, W R Grove, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of ametantrone acetate (NSC-287513)J G Kuhn, C E Balmer, T M Ludden, et al.
The American Journal of Medicine|July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinC A De Jongh, J C Wade, S C Schimpff, et al.
Pageof 5